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Background: Standard diagnostic modality to physiologically evaluate the effect of bone marrow-derived stem cell therapy on limb blood 
perfusion has not been established in patients with critical limb ischemia (CLI).
Methods: A clinical trial regarding intramuscular transplantation of granulocyte colony stimulating factor (GCSF)-mobilized CD34+ cells, an 
endothelial progenitor cell-enriched fraction, was performed in no-option patients with atherosclerotic peripheral artery disease or Buerger’s 
disease representing CLI (n=17). GCSF was subcutaneously injected for 5 days and CD34+ cells were isolated from leukoapheresis products by a 
magnetic sorting system. As efficacy parameters, we examined Wong-Baker pain rating scale, total walking distance, pain-free walking distance on 
standardized treadmill and ulcer size (sum of the maximum diameter) as well as toe brachial pressure index (TBPI), transcutaneous partial oxygen 
pressure (TcPO2) and skin perfusion pressure (SPP) at baseline and week 12 after the cell therapy.
Results: The clinical findings revealed drastic improvement of CLI at week 12 (Wong-Baker pain rating scale: baseline, 2.41±0.71 vs. week 12, 
0.71±0.99, total walking distance: 436±356 vs. 1350±352 m, pain-free walking distance: 233±320 vs. 734±356 m, ulcer size: 16.9±22.7 vs. 
2.94±5.83 mm) (p<0.05). As for the physiological parameters, TBPI (0.21±0.17 vs. 0.37±0.19) and TcPO2 (23.8±21.4 vs. 44.6±19.2 mmHg) 
significantly improved (p<0.05), however SPP was comparable after the cell therapy (13.8±7.3 vs. 17.6±7.5 mmHg, p=0.14).
Conclusion: Although SPP is generally considered to be a reliable parameter for predicting limb salvage in patients with CLI, present findings 
indicate less sensitivity of SPP to evaluate the hemodynamic effect of vascular regeneration therapy compared with TBPI and TcPO2.
